Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
about
The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug CandidatesA Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin TransporterIdentification of two novel mutations in the SLCO2A1 prostaglandin transporter gene in a Chinese patient with primary hypertrophic osteoarthropathy.Pachydermoperiostosis: a rare mimicker of acromegaly.Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.Getting more for your marrow: boosting hematopoietic stem cell numbers with PGE2.Whole-exome sequencing enables rapid determination of xeroderma pigmentosum molecular etiologyProstaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and MiceSuccess stories in genomic medicine from resource-limited countries.Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis.Primary hypertrophic osteoarthropathy: an update.Primary hypertrophic osteoarthropathy with myelofibrosis and anemia: a case report and review of literatureChronic enteropathy associated with SLCO2A1 gene (CEAS) - Characterization of an enteric disorder to be considered in the differential diagnosis of Crohn's disease.Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up.A Common Mutation and a Novel Mutation in the HPGD Gene in Nine Patients with Primary Hypertrophic Osteoarthropathy.Interleukin-6, tumor necrosis factor-alpha and receptor activator of nuclear factor kappa ligand are elevated in hypertrophic gastric mucosa of pachydermoperiostosis.Regulation of prostaglandin EP1 and EP4 receptor signaling by carrier-mediated ligand reuptake.Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)Defective SLCO2A1 does not transport PGT substrates from extracellular region to cytosolClinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention.The novel SLCO2A1 heterozygous missense mutation p.E427K and nonsense mutation p.R603* in a female patient with pachydermoperiostosis with an atypical phenotype.A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independent of age, transplant dose, and G-CSF support.Pachydermoperiostosis Masquerading as Acromegaly.
P2860
Q26795366-22B21F9B-7934-4E44-A5B3-0791DB4B8055Q28550714-FE799EDD-38DA-4DA6-9952-F50B9F460284Q33674604-D918EF6F-5FD7-4E70-B49F-21CC34E1A757Q33730669-B9B6DC3B-3F3D-44F3-BB67-8CBEA8DE47C2Q34017114-41694FF6-FB60-4A00-B7A6-239E3374F4F1Q34603339-411D8B08-511D-4228-9618-883350FEDBE7Q34765796-E4753C65-4E9C-4814-8A81-956F3D464844Q35617407-C7E09A32-3F34-4E34-B126-B1CDC093979EQ35677376-A30574EE-F0EB-4D54-B172-CC95FACD40E2Q35800006-11E782FD-31E0-4AFE-A325-C87AF049EA1CQ36809666-8C4DE11C-866C-4E81-923B-D99FDD94E6FEQ38076359-CC5A6146-D879-4E07-B52D-7C4DAF09277AQ38382590-7DBB4713-8B45-4655-8D6F-1319CE9C34E6Q39311347-C426604A-7CA0-4A90-9826-6508B28969E5Q40190397-F50F7262-A826-4A45-A9AF-B61DBF02C942Q40293283-D4818985-3686-4586-BDC7-08A209CE49C6Q40500405-770AC214-AF99-41E7-AFAD-F92737542A5EQ42105553-7595874C-6707-4AD5-B907-6AF5F11CBEBEQ45316396-34BA17BC-B328-4D83-A9ED-C52348D9C528Q50289064-BA59C4D4-C3B6-4C06-9316-2EB712A30A1BQ50714947-AA83A450-B545-462B-B39B-018229426EF5Q51177425-3BC8D9CA-57FB-4532-A031-BEC10B0A8CE8Q53082009-E57D90CB-4608-4E94-AE92-54DF67844E82Q54969394-087F59B8-8D8B-4301-9BB5-32A2D9C9EC28
P2860
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
@en
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
@en-gb
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
@nl
type
label
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
@en
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
@en-gb
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
@nl
prefLabel
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
@en
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
@en-gb
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
@en
P2093
Andrea Superti-Furga
Bowen Zhou
Bérengère Aubry-Rozier
Carolina Rivera
Colin A Johnson
Dora J Fonseca
Eamonn G Sheridan
Francesco Brancati
Ghita Harifi
P2860
P304
P356
10.1002/HUMU.22111
P50
P577
2012-05-29T00:00:00Z